Endologix, Inc. ( ELGX)

Oppenheimer 22nd Annual Healthcare Conference

December 13, 2011, 09:40 a.m. ET


John McDermott - President and CEO


Steven Lichtman - Oppenheimer


Steven Lichtman - Oppenheimer

Welcome to the 22nd Annual Oppenheimer Healthcare Conference. We are going to kick it off this morning with a few medical device names. I’m very happy to have with us, first, John McDermott, Chief Executive Officer of Endologix, pure play in the abdominal aortic aneurysms market. We are going to a presentation here in the room and then we will open it up to some Q&A here in the room as well. So, with that I’m going to turn it over to John. Thanks sir.

John McDermott

Thanks Steve. Good morning everyone. Steve pointed out we are medical device company located in Irwin, California. We focus on repair of abdominal aortic aneurysms, I have got a several slides here. I’m going to take you through these pretty quickly just to make sure that we have plenty of time at the end for Q&A. It's a large and growing market, as I take you through the product portfolio you will see that we have got a very differentiated approach relative to our competitors treating aneurysms. The company has grown nicely or direct in the U.S. going direct right now in Europe. And as you can see from the sales figures here, plenty of resources continue the growth.

If you liked this article you might like

Endologix Poised for a Potentially Volatile Breakout

5 Stocks Trending Close to Major Breakouts

5 Stocks Set for Explosive Breakouts

These 5 Stocks Under $10 Could Make You a Lot of Money

Week in Review: Trump Rally Fizzles but Stocks End 2016 With Big Gains